Central effects of converting enzyme inhibitors.

Abstract

Evidence has accumulated that systemic administration of converting enzyme inhibitors (CEI) such as captopril, MK 421 or SA 446 not only produces an inhibition of the plasma renin angiotensin system (RAS), but also of the RAS in various target organs which are relevant for blood pressure (BP) regulation. A potential target organ is the brain, where a local… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.